Biohealth Innovation
Inova announced today that Mickey Y. Kim, MD, MBA, has been named Senior Vice President of Research and Commercialization. In this role, Dr. Kim will work with Inova's institute leaders to establish Inova's research priorities, manage its portfolio, work collaboratively with Inova's external partners, and drive the commercialization of research.
Do you have experience in digital health? Are you passionate about developing innovative solutions to complex challenges? If so, consider joining the FDA Digital Health team as an Entrepreneur-in-Residence! The Center for Devices and Radiological Health (CDRH) is establishing this Entrepreneur-in-Residence (EIR) Program to support and help develop our Software Precertification (PreCert) Pilot Program —a critical piece of our Digital Health Innovation Action Plan, announced on August 8, 2017.
DATE AND TIME: Wed, September 27, 2017 8:00 AM – 10:00 AM EDT
LOCATION: 1801 Rockville Pike Suite 320 Rockville, MD 20852
Join us for our open house to connect and network in our new Rockville offices. Enjoy breakfast and discover the many services we offer to help expand business opportunities in MoCo.
We hope you can join us.
Garage parking is available in the building. If you have any questions, please contact Meaghann Diez at This email address is being protected from spambots. You need JavaScript enabled to view it..
The Institute for Bioscience and Biotechnology Research (IBBR) has been awarded a $115,000 grant to further develop and commercialize a multi-specific antibody as a therapeutic for HIV. The grant is funded under the Maryland Innovation Initiative (MII) by the Maryland Technology Development Corporation (TEDCO) that supports the commercialization of academic-based research in the State of Maryland and thereby supports the State’s efforts to foster economic development. The MII program is a collaboration between the State of Maryland and five Maryland Institutions: University of Maryland, Baltimore, University of Maryland, College Park, Morgan State University, University of Maryland Baltimore County, and Johns Hopkins University.
Wednesday, October 18 – Friday, October 20, 2017 at the MC Bioscience Education Center in Germantown, MD.
Bio-Trac® Training Programs is currently accepting preregistrations for our 2017 hands-on training workshops. Preregistration is strongly encouraged due to our small class sizes. Simply provide the few required details below and indicate applicable course(s). We will contact you directly with complete details upon receipt of your preregistration.
Johns Hopkins University moved up to 13th in the world and ninth among U.S. universities in the newest Times Higher Education world university rankings, published Tuesday.
Universities often seek to supplement their coffers by finding ways to access private-sector funds, such as by setting up technology transfer offices and trying to commercialise their research.
Five startups have been selected to participate in the inaugural M-1 Ventures health and fitness-focused accelerator program based at Johns Hopkins University.
MdBio Foundation is excited to be partnering with Verizon Innovative Learning to bring a new mobile experience to District of Columbia Public Schools. The Verizon Innovative Learning explorer lab is an entirely new way for middle school students to discover concepts of engineering design. The explorer lab is a shared immersive learning experience that combines movie-quality video, special effects, and hands-on educational gaming to create a learning environment that gets kids excited about science, technology, engineering and math (STEM) – right in the school parking lot.
It was an audacious undertaking, even for one of the most storied American companies: With a single machine, IBM would tackle humanity’s most vexing diseases and revolutionize medicine.
When Betsy Edmunds met her future husband, Hooks Johnston, through friends at a bar in New York City on March 30, 1985, she couldn't believe two things about this tired and overworked investment banker — his name, and how he spoke so earnestly about his family.
Join us on September 24, 2017 in San Jose, CA, one day before The MedTech Conference powered by AdvaMed, for the 5th Annual Pediatric Device Innovation Symposium. This year’s theme is “Partnering for Breakthroughs in Pediatric Surgery and Care.”
TOP REASONS TO ATTEND
When: Thursday, September 14, 2017 from 5:00 PM to 7:00 PM EDT
Where: BIOTrain @ Montgomery College Germantown 20200 Observation Drive Germantown, MD 20876
Join BioBuzz and sponsor BIOTrain for our next networking event and showcase of the continuing-education and workforce support programs throughout the county and state.
There also will be a tour of Montgomery College's state-of-the-art labs in the same building around 6pm.
The National Center for Advancing Translational Sciences at the National Institutes of Health has awarded Children’s National Health System, in partnership with The George Washington University (GW), another prestigious Clinical and Translational Science Award. The grant, made available to facilities across the nation through a competitive process, underwrites the existing Clinical and Translational Science Institute at Children’s National (CTSI-CN) and provides funding that is essential to continue the collaborative pediatric-focused translational research occurring at Children’s and at GW.
Experienced Startup Development Officers Help Universities, Faculty, Researchers, Students and Entrepreneurs Create, Develop and Fund University Startups and IP
Join this webinar to learn more about: How to Attract Venture Capital Wednesday, September 6, 1:00 pm ET/10:00 am PT
WHO SHOULD ATTEND: Researchers, Students, Faculty, Entrepreneurs, Startups, Vice Presidents of Research, University Tech Transfer Offices, Open Innovation Officers, Chief Innovation Officers, Angel Groups, VCs, University Venture Funds, University Angel Groups
In July 2017, Nanochon LLC and CEO Ben Holmes were awarded a Phase I SBIR grant from the National Science Foundation. The grant will fund the development of an implantable medical device for cartilage repair in the knee, based on 3D printing technology. Nanochon LLC was founded by Ben Holmes and Nathan Castro and is based on their work in Grace Zhang's Tissue Engineering Lab.
On May 11, Scott Gottlieb, M.D., officially became the 23rd commissioner of the U.S. Food and Drug Administration (FDA). Dr. Gottlieb has previous FDA experience, having served as deputy commissioner for medical and scientific affairs, among other positions, during the George W. Bush administration. More recently, he was a venture partner at the world’s largest venture capitalist firm, New Enterprise Associates (NEA), sitting on the boards of several pharmaceutical companies, including GSK, Daiichi Sankyo, and Vertex. He was also a clinical assistant professor and practiced medicine at the New York University (NYU) School of Medicine, and is a cancer survivor (Hodgkin’s lymphoma).
Maryland Tech Council CEO, Tami Howie talks with Montgomery County Economic Development Corporation for #MOCO365 on educating, advocating and connecting biotech and tech companies in Maryland.
September 28, 2017 11a PT/ 2p ET
Join us for a web panel discussion on how to successfully move a life science organization from founding to exit. During this discussion, founders will provide guidance on how executive teams can partner business and science together to overcome the stumbling blocks along the way and achieve results. Learn what is real and what is myth!
This summer in the Genetic Engineering & Biotechnology News Annual Rankings of the "Top 10 U.S. Biopharma Clusters", the BioHealth Capital Region (BHCR) moved up to #5. NIH funding, Venture Capital funding, Patents, Lab Space, and Jobs all are factored into the BHCR's move into the Top-5.
"Area biopharma leaders have committed to growing their “BioHealth Capital Region” cluster into one of the nation’s top three by 2023, building on anchors ranging from the NIH and FDA, to the nation’s top academic recipient of research grant funding, the Johns Hopkins University. Hopkins accounts for 64.5% of the region’s NIH funding (556 awards totaling $271.4 million), placing fourth with 880 awards totaling nearly $420.7 million. The region is close to meeting its goal in patents (fourth with 4,108), but further back in employment (eighth with 39,145 jobs, according to JLL) and lab space (sixth with 9.5 million square feet).
Vaccine developers continue to grow: In May, Gaithersburg-based Emergent BioSciences opened an $80 million expanded medical countermeasures plant in East Baltimore, while GlaxoSmithKline announced a $139 million capacity expansion at its API plant in Rockville, MD, due to growing demand for its lupus erythematosus treatment Benlysta® (belimumab). The region finished sixth in VC funding last year ($146 million), but climbed to fourth during Q1 (seven awards totaling $71 million). Courting the industry eagerly are both Virginia Gov. Terry McAuliffe (D) and Maryland Gov. Larry Hogan (R), a non-Hodgkin's lymphoma survivor who calls the cluster-building effort a personal mission."
We built it, but they didn’t come. In another less-than-glowing analysis of Florida’s innovation economy, the Florida Research Consortium says the state lags in overall number of scientists and in the number of scientists publishing research.
Johns Hopkins University remains the leading patent recipient in the state of Maryland.
Corporate venture capital (CVC) has long been an important source of capital for early-stage biotechs and shows no signs of diminishing, with more and more biopharma companies stepping up their investment activity.
Corporate venture firms are a well-established presence on the biotech funding scene, with the likes of Novartis and Glaxosmithkine’s SR One among the most active investors in the sector. However, the past few years have seen some different names crop up more and more: Pfizer, Celgene and Roche have noticeably stepped up their financing activity, a new analysis by EP Vantage finds.
BioMarker Strategies, LLC, today announced that the Japan Patent Office has granted new patents covering the Company’s SnapPath® Cancer Diagnostics System technology and its PathMAP® Functional Signaling Profile technology.
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
Notices
Requests for Applications
Program Announcements
The MOVE program is an innovative approach intended to attract new businesses to Montgomery County, Maryland. Eligible new businesses will receive a one-time grant upon signing a commercial lease within the county.
Businesses new to the county that lease up to 20,000 square feet of Class A or B office space may receive a grant of $8/sf. All grants are capped at 10,000 square feet for purposes of calculating the grant award.
The university and life science giants AstraZeneca and MedImmune have joined forces with the burgeoning Cambridge Biomedical Campus and pledged to work with the Government and partners in areas identified as major catalysts for growth.
In a bid to detect cancers early and in a noninvasive way, scientists at the Johns Hopkins Kimmel Cancer Center report they have developed a test that spots tiny amounts of cancer-specific DNA in blood and have used it to accurately identify more than half of 138 people with relatively early-stage colorectal, breast, lung and ovarian cancers. The test, the scientists say, is novel in that it can distinguish between DNA shed from tumors and other altered DNA that can be mistaken for cancer biomarkers.
BrainScope Company, Inc., the medical neurotechnology company which created the first FDA-cleared handheld medical device for assessment of the full spectrum of traumatic brain injury, today announced it has completed a $16 million equity financing. New investor DBL Partners joined previous backers Revolution LLC, ZG Ventures, Maryland Venture Fund and other existing and new investors in the round, which the company will use to support the commercial launch of its flagship BrainScope One medical device, as well as for continued research and development initiatives.
Tue, Sep 19, 2017 at 7:30 AM - American Visionary Art Museum800 Key HighwayJRVC 3rd FloorBaltimore, MD 21230
Already dubbed a ‘tech hub’, the Baltimore-Washington region has built a solid foundation in cyber activities as they pertain to government agencies and defense contracting. Now a transformation is underway to build up the commercial side of cyber. And that’s precisely what this panel will reinforce.
AstraZeneca has sold off marketing and development rights to another one of its pipeline assets.
This time it’s Takeda that’s stepping up, inking a deal package totaling $400 million for development and commercialization rights to its home grown MEDI1341, an alpha-synuclein antibody designed to combat Parkinson’s disease.
Virginia Bio, the premier statewide non-profit association of the life science industry in Virginia, elected Andrew J. Krouse to a two-year term as Chairman of the Board of Directors, during the annual meeting of the Board held at i.Lab at UVA.
Lightower Fiber Networks, the premier provider of all-fiber, high-performance networking solutions delivered over its own network, announced the availability of a newly constructed, all-fiber Potomac River crossing near Ashburn, VA. Wholly owned and operated by Lightower, the crossing serves as a strategic route that bypasses the greater Washington D.C. area, allowing for superior network connectivity to data centers, cloud providers, and other service locations in northern Virginia, including the Ashburn area.
AstraZeneca announced that the Food and Drug Administration (FDA) has approved Faslodex (fulvestrant) as monotherapy for use in women with hormone-receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer who are postmenopausal and have not received previous endocrine therapy.